Short-term effect of intravitreal brolucizumab injections in patients with neovascular age-related macular degeneration on retinal nerve fiber layer thickness

Abstract This study reported the short-term effects of intravitreal brolucizumab (IVB) on peripapillary retinal nerve fiber layer (RNFL) thickness in patients with neovascular age-related macular degeneration (nAMD). This retrospective observational case series included patients with nAMD treated wi...

Full description

Bibliographic Details
Main Authors: Sung Yeon Jun, Daniel Duck-Jin Hwang
Format: Article
Language:English
Published: Nature Portfolio 2023-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-32024-6
_version_ 1797836491675664384
author Sung Yeon Jun
Daniel Duck-Jin Hwang
author_facet Sung Yeon Jun
Daniel Duck-Jin Hwang
author_sort Sung Yeon Jun
collection DOAJ
description Abstract This study reported the short-term effects of intravitreal brolucizumab (IVB) on peripapillary retinal nerve fiber layer (RNFL) thickness in patients with neovascular age-related macular degeneration (nAMD). This retrospective observational case series included patients with nAMD treated with other anti-vascular endothelial growth factor (anti-VEGF) agents and subsequently switched to IVB because of poor response to those other agents on spectral domain optical coherence tomography (SD-OCT). Best-corrected visual acuity (BCVA), intraocular pressure, funduscopy, and SD-OCT were assessed at baseline, 2 weeks, 1 month, and 3 months after injection. Twenty-two patients were included in the study. In the IVB group, BCVA significantly improved 3 months after injection compared with baseline (0.45 ± 0.25 vs. 0.38 ± 0.25, p = 0.012). During the 3-month follow-up, compared with baseline, RNFL thicknesses of the global, superior temporal, inferior temporal, inferior nasal, nasal, and superior nasal sectors did not change substantially in the IVB group. However, temporal RNFL thickness significantly decreased at 1 month (p = 0.045), and the significance was lost at 3 months (p = 0.378). The central macular thickness of treated eyes significantly decreased compared with the baseline at every follow-up visit. IVB in patients with nAMD had morphological and functional visual gain effects without RNFL thinning during the short-term follow-up.
first_indexed 2024-04-09T15:09:54Z
format Article
id doaj.art-8fc7b9c1b05d42c1a1842291d9bf8729
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-09T15:09:54Z
publishDate 2023-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-8fc7b9c1b05d42c1a1842291d9bf87292023-04-30T11:15:10ZengNature PortfolioScientific Reports2045-23222023-04-011311710.1038/s41598-023-32024-6Short-term effect of intravitreal brolucizumab injections in patients with neovascular age-related macular degeneration on retinal nerve fiber layer thicknessSung Yeon Jun0Daniel Duck-Jin Hwang1Department of Ophthalmology, Hangil Eye HospitalDepartment of Ophthalmology, Hangil Eye HospitalAbstract This study reported the short-term effects of intravitreal brolucizumab (IVB) on peripapillary retinal nerve fiber layer (RNFL) thickness in patients with neovascular age-related macular degeneration (nAMD). This retrospective observational case series included patients with nAMD treated with other anti-vascular endothelial growth factor (anti-VEGF) agents and subsequently switched to IVB because of poor response to those other agents on spectral domain optical coherence tomography (SD-OCT). Best-corrected visual acuity (BCVA), intraocular pressure, funduscopy, and SD-OCT were assessed at baseline, 2 weeks, 1 month, and 3 months after injection. Twenty-two patients were included in the study. In the IVB group, BCVA significantly improved 3 months after injection compared with baseline (0.45 ± 0.25 vs. 0.38 ± 0.25, p = 0.012). During the 3-month follow-up, compared with baseline, RNFL thicknesses of the global, superior temporal, inferior temporal, inferior nasal, nasal, and superior nasal sectors did not change substantially in the IVB group. However, temporal RNFL thickness significantly decreased at 1 month (p = 0.045), and the significance was lost at 3 months (p = 0.378). The central macular thickness of treated eyes significantly decreased compared with the baseline at every follow-up visit. IVB in patients with nAMD had morphological and functional visual gain effects without RNFL thinning during the short-term follow-up.https://doi.org/10.1038/s41598-023-32024-6
spellingShingle Sung Yeon Jun
Daniel Duck-Jin Hwang
Short-term effect of intravitreal brolucizumab injections in patients with neovascular age-related macular degeneration on retinal nerve fiber layer thickness
Scientific Reports
title Short-term effect of intravitreal brolucizumab injections in patients with neovascular age-related macular degeneration on retinal nerve fiber layer thickness
title_full Short-term effect of intravitreal brolucizumab injections in patients with neovascular age-related macular degeneration on retinal nerve fiber layer thickness
title_fullStr Short-term effect of intravitreal brolucizumab injections in patients with neovascular age-related macular degeneration on retinal nerve fiber layer thickness
title_full_unstemmed Short-term effect of intravitreal brolucizumab injections in patients with neovascular age-related macular degeneration on retinal nerve fiber layer thickness
title_short Short-term effect of intravitreal brolucizumab injections in patients with neovascular age-related macular degeneration on retinal nerve fiber layer thickness
title_sort short term effect of intravitreal brolucizumab injections in patients with neovascular age related macular degeneration on retinal nerve fiber layer thickness
url https://doi.org/10.1038/s41598-023-32024-6
work_keys_str_mv AT sungyeonjun shorttermeffectofintravitrealbrolucizumabinjectionsinpatientswithneovascularagerelatedmaculardegenerationonretinalnervefiberlayerthickness
AT danielduckjinhwang shorttermeffectofintravitrealbrolucizumabinjectionsinpatientswithneovascularagerelatedmaculardegenerationonretinalnervefiberlayerthickness